Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease

Melissa K. McCoy, Terina N. Martinez, Kelly A. Ruhn, David E. Szymkowski, Christine G. Smith, Barry R. Botterman, Keith E. Tansey, Malú G. Tansey

Research output: Contribution to journalArticlepeer-review

283 Scopus citations

Fingerprint

Dive into the research topics of 'Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease'. Together they form a unique fingerprint.

Medicine & Life Sciences